168 related articles for article (PubMed ID: 16705521)
1. [Treatment of uveitis-associated refractory ocular hypotony with topical ibopamine].
Windisch BK; Iliev ME
Klin Monbl Augenheilkd; 2006 May; 223(5):422-4. PubMed ID: 16705521
[TBL] [Abstract][Full Text] [Related]
2. Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma.
Ugahary LC; Ganteris E; Veckeneer M; Cohen AC; Jansen J; Mulder PG; van Meurs JC
Am J Ophthalmol; 2006 Mar; 141(3):571-3. PubMed ID: 16490513
[TBL] [Abstract][Full Text] [Related]
3. Ibopamine treatment in chronic hypotony secondary to long-lasting uveitis. A case report.
Pivetti-Pezzi P; Da Dalt S; La Cava M; Pinca M; De Gregorio F; Virno M
Eur J Ophthalmol; 2000; 10(4):332-4. PubMed ID: 11192843
[TBL] [Abstract][Full Text] [Related]
4. Six months treatment with ibopamine in patients with hypotony after vitreoretinal surgery for retinal detachment, uveitis or penetrating trauma.
Ganteris-Gerritsen E; Ugahary LC; Jansen J; Mulder PG; Cohen AF; van Meurs JC
Retina; 2012 Apr; 32(4):742-7. PubMed ID: 21909052
[TBL] [Abstract][Full Text] [Related]
5. Topical ibopamine and corticosteroids in the treatment of post-surgery ocular hypotony.
Virno M; De Gregorio F; Pannarale L; Arrico L
Int Ophthalmol; 1996-1997; 20(1-3):147-50. PubMed ID: 9112179
[TBL] [Abstract][Full Text] [Related]
6. Surgery for hypotony in patients with juvenile idiopathic arthritis-associated uveitis.
Yu EN; Paredes I; Foster CS
Ocul Immunol Inflamm; 2007; 15(1):11-7. PubMed ID: 17365801
[TBL] [Abstract][Full Text] [Related]
7. Ibopamine provocative test and glaucoma: consideration of factors that may influence the examination.
Magacho L; Lima FE; Costa ML; Fayad FA; Guimarães NL; Avila MP
Curr Eye Res; 2004 Mar; 28(3):189-93. PubMed ID: 14977521
[TBL] [Abstract][Full Text] [Related]
8. Comparison between the 1% and 2% ibopamine provocative test in primary open-angle glaucoma patients: sensitivity, specificity and tolerability.
Magacho L; Costa ML; Dessimoni A; de Avila MP
Arq Bras Oftalmol; 2006; 69(5):695-9. PubMed ID: 17187138
[TBL] [Abstract][Full Text] [Related]
9. Hypotony maculopathy in a patient with HLA-B27-associated uveitis.
Roe R; Branco BC; Cunningham ET
Ocul Immunol Inflamm; 2008; 16(3):107-8. PubMed ID: 18569798
[TBL] [Abstract][Full Text] [Related]
10. [Positive ibopamine provocative test in normal-tension glaucoma suspects].
Kniestedt C; Romppainen T; Gloor BP; Stürmer J
Klin Monbl Augenheilkd; 2007 Apr; 224(4):255-9. PubMed ID: 17458787
[TBL] [Abstract][Full Text] [Related]
11. Pigmented deposits on a Boston keratoprosthesis from topical ibopamine.
Kanoff JM; Colby K
Cornea; 2010 Sep; 29(9):1069-71. PubMed ID: 20567201
[TBL] [Abstract][Full Text] [Related]
12. Effects of ibopamine eye drops on intraocular pressure and aqueous humor flow in healthy volunteers and patients with open-angle glaucoma.
Azevedo H; Ciarniello MG; Rosignoli MT; Dionisio P; Cunha-Vaz J
Eur J Ophthalmol; 2003 May; 13(4):370-6. PubMed ID: 12872794
[TBL] [Abstract][Full Text] [Related]
13. Severe Hypotony Maculopathy in Anterior Uveitis Associated with Hodgkin Lymphoma.
Marchese A; Giuffrè C; Miserocchi E; Cicinelli MV; Bandello F; Modorati G
Ocul Immunol Inflamm; 2021 Apr; 29(3):460-464. PubMed ID: 31647699
[No Abstract] [Full Text] [Related]
14. The effects of 2% ibopamine eye drops on the intraocular pressure and pupil motility of patients with open-angle glaucoma.
Giuffrè I; Taverniti L; Di Staso S
Eur J Ophthalmol; 2004; 14(6):508-13. PubMed ID: 15638100
[TBL] [Abstract][Full Text] [Related]
15. The comparison of topical ibopamine 2% with tonography to identify the outflow resistance in eyes with ocular hypertension.
Hepsen IF; Yilmaz H; Keskin UC
Ophthalmic Res; 2005; 37(1):17-22. PubMed ID: 15627837
[TBL] [Abstract][Full Text] [Related]
16. Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases.
Landers J; Ullrich K; Craig JE
Clin Exp Ophthalmol; 2015 Dec; 43(9):808-14. PubMed ID: 26140527
[TBL] [Abstract][Full Text] [Related]
17. Increase in aqueous humor production following D1 receptors activation by means of ibopamine.
Virno M; Taverniti L; De Gregorio F; Sedran L; Longo F
Int Ophthalmol; 1996-1997; 20(1-3):141-6. PubMed ID: 9112178
[TBL] [Abstract][Full Text] [Related]
18. Pupillographic evaluation of the mydriatic effect of ibopamine solution.
Gelmi C; Palazzuolo A; Lucchetti M; Trimarchi F
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):346-51. PubMed ID: 2777423
[TBL] [Abstract][Full Text] [Related]
19. Flare-up rates with bimatoprost therapy in uveitic glaucoma.
Fortuna E; Cervantes-Castañeda RA; Bhat P; Doctor P; Foster CS
Am J Ophthalmol; 2008 Dec; 146(6):876-82. PubMed ID: 19027422
[TBL] [Abstract][Full Text] [Related]
20. Ibopamine challenge test can be used to differentiate glaucoma suspects from glaucoma patients.
Ullrich K; Craig JE; Landers J
Clin Exp Ophthalmol; 2014; 42(4):342-6. PubMed ID: 24034130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
